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When the data won’t get you there: The ethics of
scientific error, and worse
James W. Jones, MD, PhD, MHA, Laurence B. McCullough, PhD, and Bruce W. Richman, MA,
Houston, TexasI was crazy with work. I could see nothing in front of me. I
saw only one thing, and that was how my country could
stand straight in the center of the world.
Hwang Woo Suk
A surgical scientist is informed by his research
assistant and statistician, after they’ve reviewed data for
a new publication, that the conclusions of a previously
published paper may be incorrect. The prospectively
collected data were assembled from experiences at sev-
eral hospitals. The criteria for inclusion were not pre-
cisely observed, and a number of experimental-arm
patients at one institution were mistakenly excluded
from the analysis after enrollment. A computer glitch
has corrupted much of the original data, and the back-
ups are not to be found. Huge study samples and data
sets, and the long interval since the data were collected,
make chart retrieval effectively impossible. The study’s
conclusion did not alter conventional surgical practice;
it supported current assumptions and techniques. The
statistician now cannot confirm whether the data did or
did not support the conclusions. The people who
worked on the project all feel that even if the contam-
inated data were excluded, the recalculated data would
support the published paper. But a recalculation is not
possible. What should be done?
A. Send a retraction to the journal that published the
original paper.
B. The paper does not change the practice of surgery. He
should do nothing.
C. The paper’s problems were discovered by a fluke. He
should do nothing.
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1308D. Friends at his institution advise against a retraction.
They say it will unnecessarily damage both his and the
university’s reputations. He should do nothng.
E. Confer with friends on the journal’s editorial board
about what should be done. If they agree to let the
paper stand as published, he should do nothing.
Since the turn of the new century, editorial staffs of the
leading scientific journals have worked harder than ever to
forestall publication of tainted material. The most prominent
peer-reviewed journals have made substantial progress in rid-
ding their pages of data manipulated for private advantage by
industry, gift authorship, and multiply published data. Edito-
rials, policy statements, authorship verification forms, certifi-
cations of authorial independence in industry-sponsored stud-
ies, confirmation of institutional review board approval, and
disavowals of conflicts of interest have lately become com-
monplace. These are indeed important measures to ensure
that the distribution of scientific information is governed by
honesty, integrity, and care.
As important as valid authorship and disclosure of
conflicts of interest are, the veracity of scientific publication
is entirely dependent on the authors’ data management
procedures. Peer reviewers have to assume that the study
was conducted as described. They assess whether the meth-
odology seems scientifically sound, whether the data accu-
rately support the conclusions, and whether those conclu-
sions seem sufficiently important to warrant their journal’s
imprimatur. There is almost no feature of the peer-review
system designed for the detection of intentional fraud or
scientific incompetence if the investigators have somehow
managed to make their methods, data, and conclusions
look internally consistent.
Objective and accurate publication, carefully written by
knowledgeable and responsible investigators and thinkers,
is the primary medium through which the medical profes-
sion distributes its most important information. The pro-
cess relies entirely for its authority upon the personal integ-
rity and effectiveness of the participants, a confidence that
physicians and scientists will practice medicine and conduct
research consistent with standards of intellectual and moral
excellence.1
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amazement when Dr Hwang Woo Suk’s claims to have
successfully cloned a human embryo in his South Korean
lab were exposed as false in January of this year. As unpleas-
ant news so often seems to cluster, other prominent inter-
national scientific frauds lately have come to light:
● The New England Journal of Medicine found that the
authors of a Vioxx study it had published had inten-
tionally failed to report an unusual incidence of heart
attacks among study patients.2
● A Norwegian, Jon Sudbo, published an article in The
Lancet featuring fabricated data that he gathered from
“thin air” on the lifestyles of 900 nonexistent sub-
jects.3
● A Japanese biochemist’s work was declared science
fiction when it could not be reproduced.4
In each of these cases, discovery and discredit followed
skeptical inquiry by others, usually offended associates, not
spontaneous remorse and recantation by the charlatans.
The immediate damage done to the authenticity of the
scientific literature is only the most obvious consequence of
these wicked shenanigans. The current champion of scien-
tific serial fraud appears to be Eric Poehlman, who has
admitted to 54 counts of falsifying data and has retracted 10
published papers.5 Sox and Rennie6 examined the fallout of
Poehlman’s publications and found his papers cited 3700
times. Incredibly, this serial fraudster’s papers continued to
be quoted even after retractions had been published!6
Hwang Woo Suk has done more to cause public mistrust of
scientists more than anyone since Dr Frankenstein, and his
malfeasance has given aid and comfort to the factions
promoting complete bans on stem cell and cloning research
and favoring other manifestations of anti-scientific, anti-
intellectual neo-know-nothingism.
Fraudulent reports send subsequent researchers down
blind alleys, waste the precious time and resources of rep-
utable scientists who work to replicate work that isn’t
replicable, and shoulder the pretenders to the head of the line
in competing for scarce grant support to which they haven’t
earned entitlement, while denying it to legitimate investiga-
tors. Scientific fraud is a very serious crime, with the potential
to threaten the health and lives of every one of us.
Falsifying data is surely the most egregious offense to
scientific integrity, but it is only one of many ways in which
distortion can be introduced to the scientific system.7 Gen-
erated errors can be located in the design, conduct, analysis,
or reporting of a study. Over-interpretation of significant
findings in small trials, selective reporting of results in the
abstract, cavalier methodology, failure to report outcomes
that don’t support the hypothesis, and use of multiple
statistical methods until positive results are obtained all
assault the integrity of the scientific process.
The February issue of the Journal of Vascular Surgery
printed a heart-wrenching retraction of a flawed article
which had appeared more than a year earlier. The request
for retraction by the principal investigator was accompanied
by an equally anguished letter by the journal’s editors.8 Theoriginal paper, published as the lead article in the December
2004 issue of this journal,9 described a new and effective
method for preventing kidney failure during thoracoab-
dominal aortic aneurysm (TAA) repair, a tenacious prob-
lem with vast implications for postoperative morbidity and
mortality. The paper was hailed as “a lofty benchmark in
TAA surgery” by its invited commentator, who predicted
that it would probably influence future practice in aneu-
rysm repair. A happy occasion indeed.
But the authors subsequently had occasion to revisit their
data, and they found flaws in their collection and assessment
method which had previously escaped them. It’s not hard to
sense the drama that unfolded here, beginning with the ela-
tion of what was believed to be a landmark finding, something
that would lessen a dreaded complication and genuinely ad-
vance the practice of surgery, followed by a review of data and
a dawning realization that perhaps the results were not what
they were thought to be, then watching hopes of salvaging the
moment with a new data analysis vaporize, and the culminat-
ing despair of the decision to face the professional community
and withdraw the paper.
Dr Jacobs’ experience cautions us against a dangerous
blind spot in the surgical literature, the honest mistakes that
can happen when reporting a large operative experience.
The mainstay of the surgical literature is retrospective anal-
ysis of large clinical experiences. The subject cases are
usually accumulated over a long period of time, perhaps an
entire career, and as with Dr Jacobs’ sample, at different
institutions. Busy practicing surgeons usually have data
collected, maintained, and analyzed wholly or in part by
surrogates, fellows, residents on research rotations, lab
assistants, and statisticians. The clinical “experience” can be
packaged into categories of treatment that may be only
loosely scientific, but are still susceptible to quantification
and statistical analysis if the methodology is clearly pub-
lished. These potential sources of creeping error absolutely
require the senior surgeon to be more closely involved in
the data gathering and preparation process than many
currently are. As Dr Jacobs wrote so cogently:
The main lesson is that the principle investigator should
have and keep control on the entire “life cycle” of a
retrospective clinical study, especially if the study has a
long history. This life cycle not only includes the design of
the study protocol, assessment, and writing the manu-
script, but also collecting the data. Specific data sets that
have been used for other publications cannot automati-
cally be pooled for another article before reassessment of
the individual data confirms alignment with the study
protocol and definitions. This certainly accounts for data
derived from different centers.8
The concept was further articulated by Drs Cronenwett and
Seeger in their response to Dr Jacob’s letter.
Integrity is derived etymologically from the same root
as integer, indicating wholeness or completeness, with
nothing hidden or missing. It can be used to mean the
comprehension and fidelity necessary to the enactment of
sound moral principles. Scientific and clinical integrity, the
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adherence to time-tested standards of research methodol-
ogy, especially when no one is watching. The integrity of the
scientific process depends vitally on such self-monitoring and
self-mastery. Most of us have a tendency to want to see our
hypotheses supported at the conclusion of a research study,
but that taint of pride in our own cleverness and insightfulness
can be a terrible blind spot, and ultimately a contaminant to
good science. Surgeon-investigators must therefore closely
monitor themselves for bias and, worse, a tipping of the
data to confirm a prior supposition. The publication of
negative data will seldom be as exciting as a startling new
finding, and in fact even the best journals are less apt to
accept such articles, but other investigators and ultimately
our patients depend upon the accuracy of our reports, and
upon our comprehensive integrity. Dr Jacobs got it right
and so should the surgeon with whom we began this
discussion. An explanation of the errors and a retraction of
the paper should be prepared and sent to the journal
forthwith. Option A is the ethically correct course of action.
The argument that the accuracy of the publication in
our opening scenario is inconsequential, and can be safely
ignored because the article does not influence current
clinical practice, forgets that science is a continual hunt for
truth, not a destination. Science denies the existence of
ultimate truth, and none of us can conceive of a condition
at which the state of knowledge will be considered com-
plete and further inquiry redundant. If the paper was im-
portant enough to publish in the first place, it is important
enough to correct. A bad paper can stifle subsequent ad-
vances by misdirecting investigators who use it to prepare
for some next inquiry, or by leading them to believe that a
problem has been solved when it has not.
Does it not seem odd to repeatedly find large published
clinical studies totally contradicting one another’s conclu-
sions more often than in literature of other nonclinical
disciplines? Reproducibility is essential to scientific truth
the violation of which should lead to questions as in the case
of the Japanese biochemist, found guilty of fraud. In clinical
medicine, we perfunctorily dismiss clinical contradictions as
“different” experiences from different institutions. How
much equipoise in surgical literature is related to data
problems? If an inaccurate report does not affect patient
care now, it likely will later. Option B must be rejected.
How the inaccuracies were discovered clearly makes no
difference at all to how our surgeon should react to them.
Many of medicine’s greatest discoveries were serendipitous.
Surely no one would suggest that penicillin should not have
been used in patient care because its effectiveness was
discovered by accident. Option C is not the right choice.
A prevalence of faculty colleagues who recommend
unethical behavior may indicate a serious institutional de-
fect. Avoiding potential damage to one’s reputation is a
legitimate concern; most of us work very hard to establish
good reputations within our profession, and none of us
would lightly dispense with them. But good reputations are
properly earned and kept by striving to advance the profes-sion’s ideals and body of knowledge, not by striving to
advance personal egos. Admission of a mistake will always
be a lot less damaging than discovery of a fraud. By failing
to report a flawed study when discovered, an honest or
careless mistake becomes fraud. Certainly a scientist’s rep-
utation and future credibility would be elevated within the
profession by admission of imperfections in a publication so
long as they were inadvertent not intentional or repeated.
Dr Hwang, who kept his dark secrets, is unlikely to ever
again be believed or respected within the scientific commu-
nity. Option D is the wrong choice.
Once the investigator has found that a paper is of ques-
tionable reliability, the temptation to manipulate professional
friendships to gain absolution has to be resisted. The investi-
gator who has published a significant error is properly embar-
rassed, but he must recognize that he has placed the journal
and its editors in an embarrassing situation as well. Our most
trusted journals have gained their exalted status within the
profession by printing work of consistently high quality, rig-
orously conducted, and absolutely trustworthy. Journals that
publish articles that don’t meet these standards are called
throwaways. Our surgeon must not add insult to injury by
asking the editors whom he’s embarrassed to somehow miti-
gate his error and soften his embarrassment. Option E should
be rejected. The errant author must request retraction of the
flawed paper without presuming to further compromise the
journal’s institutional integrity.
Retractions of publications are very rare in the surgical
literature. Searching the literature for withdrawals of arti-
cles published in peer-reviewed journals yielded a dozen
cases, most of which involved medical devices, not surgical
techniques. Could Dr Jacobs be one of the few surgeons to
have discovered errors in his published data, or is he just
one of a very few to honestly correct what he found?
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